BioGaia AB (BIOGY)
11.50
0.00 (0.00%)
USD |
OTCM |
Jul 02, 16:00
BioGaia Profit Margin (Quarterly): 32.95% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 32.95% |
December 31, 2023 | 22.62% |
September 30, 2023 | 31.95% |
June 30, 2023 | 25.55% |
March 31, 2023 | 31.69% |
December 31, 2022 | 50.83% |
September 30, 2022 | 30.85% |
June 30, 2022 | 27.26% |
March 31, 2022 | 26.88% |
December 31, 2021 | 18.57% |
September 30, 2021 | 30.40% |
June 30, 2021 | 26.93% |
March 31, 2021 | 24.97% |
December 31, 2020 | 20.50% |
September 30, 2020 | 15.52% |
June 30, 2020 | 32.30% |
March 31, 2020 | 22.84% |
December 31, 2019 | 25.31% |
September 30, 2019 | 22.76% |
June 30, 2019 | 27.46% |
March 31, 2019 | 20.84% |
December 31, 2018 | 27.21% |
September 30, 2018 | 29.46% |
June 30, 2018 | 31.24% |
March 31, 2018 | 27.55% |
Date | Value |
---|---|
December 31, 2017 | 28.42% |
September 30, 2017 | 28.54% |
June 30, 2017 | 30.23% |
March 31, 2017 | 30.39% |
December 31, 2016 | 33.86% |
September 30, 2016 | 27.82% |
June 30, 2016 | 28.35% |
March 31, 2016 | 79.91% |
December 31, 2015 | 20.90% |
September 30, 2015 | 19.50% |
June 30, 2015 | 26.63% |
March 31, 2015 | 31.14% |
December 31, 2014 | 14.74% |
September 30, 2014 | 18.31% |
June 30, 2014 | 19.23% |
March 31, 2014 | 51.54% |
December 31, 2013 | 18.07% |
September 30, 2013 | 21.60% |
June 30, 2013 | 17.91% |
March 31, 2013 | 21.38% |
December 31, 2012 | 20.52% |
September 30, 2012 | 22.05% |
June 30, 2012 | 20.41% |
March 31, 2012 | 65.12% |
December 31, 2011 | 24.77% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
15.52%
Minimum
Sep 2020
50.83%
Maximum
Dec 2022
27.40%
Average
26.88%
Median
Mar 2022
Profit Margin (Quarterly) Benchmarks
Abliva AB | -- |
Karolinska Development AB | 44.16% |
Calliditas Therapeutics AB | -83.31% |
Oncopeptides AB | -1.45K% |
Olink Holding AB | -55.87% |
Profit Margin (Quarterly) Related Metrics
Return on Equity | 18.28% |
Return on Assets | 16.00% |
Return on Invested Capital | 18.28% |
Gross Profit Margin (Quarterly) | 71.89% |
Operating Margin (Quarterly) | 38.72% |
Return on Net Operating Assets | 76.99% |